Cargando…
Silencing of immune activation with methotrexate in patients with COVID-19
Autores principales: | Safavi, Farinaz, Nath, Avindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247505/ https://www.ncbi.nlm.nih.gov/pubmed/32471659 http://dx.doi.org/10.1016/j.jns.2020.116942 |
Ejemplares similares
-
Neurological issues during COVID-19: An overview
por: Nath, Avindra, et al.
Publicado: (2021) -
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
por: Safavi, Farinaz, et al.
Publicado: (2020) -
Neuropathic symptoms with SARS-CoV-2 vaccination
por: Safavi, Farinaz, et al.
Publicado: (2022) -
HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19
por: Garcia-Montojo, Marta, et al.
Publicado: (2021) -
Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)